Convallamarin
Names | |
---|---|
Systematic IUPAC name
(1β,3β,5β,22R)-3-{[6-Deoxy-4-O-(β-D-glucopyranosyl)-β-D-gulopyranosyl]oxy}-26-(β-D-galactopyranosyloxy)-22-hydroxyfurost-25(27)-en-1-yl 6-deoxy-4-O-(6-deoxy-β-D-gulopyranosyl)-β-D-allopyranoside | |
Identifiers | |
1391-12-4 | |
3D model (Jmol) | Interactive image |
ChemSpider | 4884540 |
ECHA InfoCard | 100.014.298 |
EC Number | 215-728-6 |
PubChem | 23304308 |
| |
| |
Properties | |
C57H94O27 | |
Molar mass | 1,211.35 g·mol−1 |
Appearance | Yellowish-white crystalline powder |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Convallamarin[1] is a crystalline glycoside extracted from Convallaria majalis.[2]
References
- ↑ "CONVALLAMARIN : MP Biomedicals". Retrieved 21 July 2010.
- ↑ "Materia Medica, General Therapeutics, and Pharmacy". The American Journal of the Medical Sciences. 57 (114): 527–528. April 1869.
This article is issued from Wikipedia - version of the 3/16/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.